BioStock: Medivir – live from ESMO in Barcelona

At the ESMO conference in Barcelona, Medivir presented mature results from its ongoing Phase Ib/IIa trial of fostrox in combination with Lenvima, confirming the potential for improved outcomes in advanced liver cancer. BioStock contacted Dr. Pia Baumann, Medivir’s Chief Medical Officer, who joined us live from Barcelona.

See the video interview with Dr. Pia Baumann at biostock.se:

https://www.biostock.se/en/2024/09/medivir-live-from-esmo-in-barcelona/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/